Simieli Lucas, Vitório Rodrigo, Rodrigues Sérgio Tosi, Zago Paula Fávaro Polastri, Ignacio Pereira Vinícius Alota, Baptista André Macari, de Paula Pedro Henrique Alves, Penedo Tiago, Almeida Quincy J, Barbieri Fabio Augusto
São Paulo State University - Campus Bauru, Human Movement Research Laboratory (MOVI-LAB) and Laboratory of Information, Vision and Action (LIVIA), Department of Physical Education, Brazil.
São Paulo State University - Campus Rio Claro, Posture and Gait Studies Laboratory (LEPLO), Department of Physical Education, Brazil.
Gait Posture. 2017 Oct;58:504-509. doi: 10.1016/j.gaitpost.2017.09.016. Epub 2017 Sep 20.
The aim of this study was to analyze the motor and visual strategies used when walking around (circumvention) an obstacle in patients with Parkinson's disease (PD), in addition to the effects of dopaminergic medication on these strategies. To answer the study question, people with PD (15) and neurologically healthy individuals (15 - CG) performed the task of obstacle circumvention during walking (5 trials of unobstructed walking and obstacle circumvention). The following parameters were analyzed: body clearance (longer mediolateral distance during obstacle circumvention of the center of mass -CoM- to the obstacle), horizontal distance (distance of the CoM at the beginning of obstacle circumvention to the obstacle), circumvention strategy ("lead-out" or "lead-in" strategy), spatial-temporal of each step, and number of fixations, the mean duration of the fixations and time of fixations according to areas of interest. In addition, the variability of each parameter was calculated. The results indicated that people with PD and the CG presented similar obstacle circumvention strategies (no differences between groups for body clearance, horizontal distance to obstacle, or obstacle circumvention strategy), but the groups used different adjustments to perform these strategies (people with PD performed adjustments during both the approach and circumvention steps and presented greater visual dependence on the obstacle; the CG adjusted only the final step before obstacle circumvention). Moreover, without dopaminergic medication, people with PD reduced body clearance and increased the use of a "lead-out" strategy, variability in spatial-temporal parameters, and dependency on obstacle information, increasing the risk of contact with the obstacle during circumvention.
本研究的目的是分析帕金森病(PD)患者在绕过障碍物行走(规避)时所采用的运动和视觉策略,以及多巴胺能药物对这些策略的影响。为了回答研究问题,帕金森病患者(15名)和神经功能正常的个体(15名 - 对照组)在行走过程中执行了绕过障碍物的任务(5次无障碍行走和绕过障碍物的试验)。分析了以下参数:身体间隙(在绕过障碍物时,质心 -CoM- 到障碍物的左右方向较长距离)、水平距离(在开始绕过障碍物时质心到障碍物的距离)、规避策略(“引出”或“引入”策略)、每一步的时空参数、注视次数、注视的平均持续时间以及根据感兴趣区域的注视时间。此外,还计算了每个参数的变异性。结果表明,帕金森病患者和对照组呈现出相似的障碍物规避策略(在身体间隙、到障碍物的水平距离或障碍物规避策略方面,两组之间没有差异),但两组在执行这些策略时采用了不同的调整方式(帕金森病患者在接近和绕过步骤中都进行了调整,并且对障碍物表现出更大的视觉依赖;对照组仅在绕过障碍物前的最后一步进行了调整)。此外,在没有多巴胺能药物的情况下,帕金森病患者会减小身体间隙,增加“引出”策略的使用、时空参数的变异性以及对障碍物信息的依赖,从而增加在规避过程中与障碍物接触的风险。